Indlæser Begivenheder

Second Scandinavian Baltic Pancreas Symposium

Second Scandinavian Baltic Pancreas Symposium

Second International OPAC Symposium

September 30 – October 1, 2022 Hindsgavl Castle, Middelfart, Denmark

 

Pris: 1800-2800 DKK

 

Dear colleagues,

Odense Pancreas Center (OPAC, Odense University Hospital), Center for Pancreatic Diseases (Aalborg University Hospital) and Pancreas Center East (Hvidovre University Hospital) are happy to announce the Second Scandinavian Baltic Pancreas Symposium – Second International OPAC Symposium. The symposium will cover several aspects of benign and malignant pancreatic diseases, but with special emphasis on Pancreatic Cancer, Chronic Pancreatitis and Hypoglycemia.

The symposium includes State-of-the-Art Lectures, Meet the Experts, Breakout Sessions and QR Based Competition as well as Poster Exhibition and Awards (see programme below)

We hope that you will join the symposium, and that you may consider submitting an abstract for the Poster Exhibition. An expert committee will evaluate all posters, and the three best posters will be presented orally and awarded on Friday evening.

More information and registration are available on www.OPAC.nu

 

Looking forward to seeing you at the symposium,

 

Professor Asbjørn Drewes                                                    Professor Michael Bau Mortensen

Professor, Consultant, PhD, DMSc                                       Professor, Consultant, PhD, DMSc

Centre for Pancreas Diseases                                               Odense Pancreas Center (OPAC)

Aalborg University Hospital                                                 Odense University Hospital

 

PROGRAM

Second Scandinavian Baltic Pancreas Symposium Second International OPAC Symposium

Hindsgavl Castle, Middelfart September 30 – October 1, 2022

Friday September 30, 2022

 

09.00 – 10.00 REGISTRATION & COFFEE AND BREAKFAST

10.00 – 12.30 PLENARY SESSION 1
10.00 – 10.15 WELCOME
10.15 – 10.45 Clinical aspects of autoimmune pancreatitis (Miroslav Vujasinovic,
  Stockholm)
10.45 – 10.50 Q & A
10.50 – 11.20 Congenital Hyperinsulinism; The past, present and the future
  (Henrik Christesen, Odense)
11.25 – 11.30 Q & A
BREAK (15 min.)
11.45 – 12.10 Update on WHO classification of pancreatic neoplasms (Volkan
  Adsay, Istanbul)
12.10 – 12.15 Q & A
12.15 – 12.40 Neoadjuvant treatment of pancreatic cancer (Per Pfeiffer,
  Odense)
12.40 – 12.45 Q & A
12.45 – 13.30 Lunch & Exhibition

 

 

13.30 – 14.30 BREAKOUT SESSIONS I
 

Pancreatic cancer

 

Hypoglycemia

 

Chronic Pancreatitis

Histologic tumor regression grading in preoperatively treated pancreatic cancer (Caroline Verbeke, Oslo)

 

Pancreatic neuroendocrine neoplasms (NENs) (Volkan Adsay, Istanbul)

Hyperinsulinism in Ukraine (Evgenia Globa, Ukraine)

 

 

 

Parental experiences with congenital hyperinsulinism (Louise and Thomas Grave-Larsen Farum, Meina Jia Sandal and Søren Sandal Lystrup)

The spectrum of diabetes in acute and chronic pancreatitis (Søren Schou Olesen, Aalborg)

 

 

Endoscopic treatment of pancreatic duct leakage (Stine Roug, Hvidovre)

 

14.30 – 15.00 POSTER WALK

15.00 – 15.45 COFFEE, EXHIBITION & NETWORKNING

15.45 – 17.15 PLENARY SESSION 2
 
15.45 – 16.10 Surgical treatment of pain in patients with chronic
  pancreatitis (Yama Issa, Amsterdam)
16.10 – 16.15 Q & A
16.15 – 16.40 Pain management of acute and chronic pancreatitis, and
  pancreas cancer (Asbjørn Drewes, Aalborg)
16.40 – 16.45 Q & A
16.45 – 17.10 Ten years’ experience – and lessons learned from the Danish
  Pancreatic Cancer Database (Claus Fristrup, Odense)
17.10 – 17.15 Q & A
17.15 – 18.00 PLENARY SESSION 3
Oral Presentations & Prices

19.00 DRINKS & DINNER

 

 

 

Saturday October 1, 2022


07.30-08.30 Walk & Talk or 5 km run at Hindsgavl Castle

 

09.00 – 09.45 MEET THE EXPERTS
Hot topics in Hypoglycemia Glucagon as a new medical treatment for hyperinsulinism (Indi

Banerjee, Manchester)

Hot topics in Chronic pancreatitis Imaging in chronic pancreatitis (Jens Brøndum Frøkjær, Aalborg)
Hot topics in Pancreatic Cancer IRE vs SBRT vs proton treatment in locally advanced and irresectable

pancreatic cancer (Per Pfeiffer, Odense)

 

 

10.00 – 12.00 BREAKOUT SESSIONS II
Rising stars

(90 minutes)

Rising stars

(90 minutes)

Rising stars

(90 minutes)

Prognostic significance of margin clearance in surgically treated pancreatic cancer (Trine Aaquist)

 

 

Accuracy and clinical outcomes of pancreatic EUS-FNB in a consecutive series of 852 specimens (Mikkel Marschall Thomsen)

PIPAC directed therapy in peritoneal metastasis from PDAC (Line Schmidt Tarpgaard & Martin Graversen)

 

Stereotactic body radiotherapy (SBRT) in patients with locally advanced pancreatic cancer (Mathilde Weisz Ejlsmark)

Rational and protocol for the PAMORA-AP study (Cecilie Siggard Knoph)

 

 

Assessment of pain in chronic pancreatitis (Louise Kuhlman Asferg)

 

 

Extra-pancreatic complications in chronic pancreatitis (Amer Hadi)

11.00 – 11.30 COFFEE & EXHIBITION

 

Utility of EUS-guided through- the-needle biopsy from pancreatic cystic lesions (Charlotte Vestrup Rift) Molecular features of familial pancreatic cancer (FPC) (Ming Tan) Advanced investigations in unexplained hypoglycemia in children with atypical pancreatic histology (Annette Rønholt Larsen)

Genetic alterations in insulinomas from young patients with and without multiple endocrine neoplasia type 1

(MEN1) (Kirstine Øster Andersen)

 
Test your knowledge on pancreatic diseases during the Lunch Break and win the QR based competition!

12.00 – 13.00 LUNCH – COFFEE & EXHIBITION

 

 

 

13.00 – 15.00 PLENARY SESSION 4
Upcoming Research in Pancreatic Diseases
13.00 – 13.15 Test your knowledge – results and winner! (Claus Fristrup,
  Odense)
13.15 – 13.40 Robot assisted pancreatic surgery (Christian Benzing, Berlin)
  Q & A
13.40 – 13.45  
  Personalized medicine in pancreatic cancer (Morten Ladekarl,
13.45 – 14.10 Aalborg)
  Q & A
14.10 – 14.15  
  Cell therapy providing a curative treatment for type 1
14.15 – 14.40 diabetes: Is it possible? (Jacob Sten Petersen; Copenhagen)
  Q & A
14.40 – 14.45  
14.45 – 15.00 SUMMARY
End of Symposium